SEC Filings

MEDTRONIC PLC filed this Form DEFR14A on 10/11/2017
Entire Document



The following table presents fees for professional audit services rendered by PricewaterhouseCoopers for the audit of Medtronic’s annual financial statements for the fiscal years ended April 29, 2016 and April 28, 2017, and fees for other services rendered by PricewaterhouseCoopers. All of the audit, audit-related, tax and all other fees were approved by the Audit Committee.


   Fiscal 2016   Fiscal 2017 
Audit Fees(1)  $16,652,000    16,369,000 
Audit-Related Fees(2)   521,000    2,821,000 
Tax Fees(3)   3,045,000    2,072,000 
All Other Fees(4)   19,000    134,000 
(1) Audit services consisted principally of domestic and international audits, statutory audits and assessment of internal control over financial reporting.
(2) Audit-related services consisted principally of non-recurring procedures in connection with the Company’s plan to sell the Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses within the PMR division of our Minimally Invasive Therapies Group to Cardinal Health Inc.
(3) Tax-related services consisted principally of services related to assistance with transfer pricing, tax compliance, tax planning, and tax audits.
(4) Other service fees consisted principally of services related to special non-audit reports.


MEDTRONIC PLC   2017 Proxy Statement    66